TP53 and urinary bladder carcinoma: Interestingly, multiple recent studies show that emetine inhibited bladder cancer cell proliferation [32], leukemia cells [33], and ovarian cancer cells [34], suggesting it as a potential novel therapy for p53-like bladder cancers.